Potassium%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCl) is an essential electrolyte used to treat or prevent hypokalemia. It is available in oral and intravenous (IV) formulations. ## Primary Indications * Treatment of hypokalemia. * Prevention of hypokalemia, particularly in patients receiving diuretics that waste potassium or in those with significant potassium losses. ## Adult Dosing * **Oral:** * **Treatment of Hypokalemia:** Typically 20-40 mEq (or mmol) per dose, given 2-4 times daily. Doses up to 100 mEq (or mmol) per day may be required. * **Prevention of Hypokalemia:** Typically 20 mEq (or mmol) per day. * **Intravenous (IV):** * **Treatment of Hypokalemia:** Doses vary greatly depending on serum potassium levels and patient condition. Mild hypokalemia (serum K+ 3.0-3.4 mEq/L) may be treated with 20-40 mEq (or mmol) added to IV fluids. Severe hypokalemia (serum K+ < 2.5 mEq/L) may require 60-100 mEq (or mmol) or more over 24 hours. * **Maximum IV Infusion Rate:** Generally, do not exceed 10 mEq (or mmol) per hour peripherally or 20 mEq (or mmol) per hour centrally to avoid phlebitis and cardiac arrhythmias. Higher rates (up to 40 mEq/hour) may be used in emergent situations with continuous cardiac monitoring, but this depends on local protocol. * **Maximum Concentration:** Typically 40 mEq (or mmol) per liter for peripheral IVs, up to 80 mEq (or mmol) per liter for central IVs. ## Pediatric Dosing * Dosing is based on patient weight and serum potassium levels, and often follows specific institutional protocols. * **Oral:** Typical maintenance is 1-2 mEq/kg/day, divided into doses. Treatment doses can be higher. * **Intravenous (IV):** * **Maximum Daily Dose:** 3-4 mEq/kg/day. * **Maximum Infusion Rate:** 0.5-1 mEq/kg/hour, not to exceed 10-20 mEq/hour (depending on access). ## Dose Adjustments * **Renal Impairment:** Use with extreme caution. Potassium is primarily excreted by the kidneys. Dosage reduction or discontinuation may be necessary. Monitor serum potassium closely. * **Hepatic Impairment:** No specific adjustment, but monitor electrolytes. ## Contraindications * Hyperkalemia. * Conditions that predispose to hyperkalemia, such as severe renal impairment, untreated Addison's disease, and certain metabolic disorders. * Use of potassium-sparing diuretics concurrently in patients with impaired renal function. ## Adverse Effects * **Gastrointestinal:** Nausea, vomiting, abdominal pain, diarrhea, gastrointestinal obstruction or bleeding (especially with sustained-release oral formulations). * **Cardiovascular:** Hypotension, bradycardia, cardiac arrhythmias, cardiac arrest (especially with rapid IV infusion or hyperkalemia). * **Other:** Hyperkalemia, phlebitis (with IV administration). ## Key Drug Interactions * **Potassium-Sparing Diuretics (e.g., spironolactone, amiloride, triamterene):** Increased risk of hyperkalemia. * **ACE Inhibitors/Angiotensin Receptor Blockers (ARBs):** Increased risk of hyperkalemia. * **NSAIDs:** Can reduce renal potassium excretion, increasing risk of hyperkalemia. * **Digoxin:** Hyperkalemia can increase the risk of digoxin toxicity. Hypokalemia can increase the risk of digoxin toxicity. * **Beta-Blockers:** May cause hyperkalemia, especially in patients with renal impairment. ## Monitoring * Serum potassium levels (frequency depends on severity of hypokalemia, IV infusion rate, and renal function). * Renal function (BUN, creatinine). * Electrocardiogram (ECG) for signs of hyperkalemia (tall peaked T waves, flattened P waves, widened QRS complex). * Signs and symptoms of hypokalemia (muscle weakness, fatigue, constipation, arrhythmias). * Signs and symptoms of hyperkalemia (muscle twitching, weakness, numbness/tingling, slow/irregular heartbeat). ## Clinical Pearls * Oral potassium chloride should be taken with meals or a full glass of water to minimize gastrointestinal irritation. * Do not crush or chew sustained-release oral formulations. * IV potassium chloride should always be diluted and administered with caution due to the risk of serious adverse events, including cardiac arrest. * Always verify the specific concentration and infusion rate with pharmacy and follow institutional guidelines, especially for IV administration. --- ***Disclaimer:** This information is intended for clinical use and is not a substitute for professional medical advice. Always consult the most current prescribing information and institutional protocols for definitive guidance. Dosing and recommendations may vary based on individual patient factors and clinical circumstances.*